Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 6;70(10):2238-2239.
doi: 10.1093/cid/ciz835.

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?

Auke E S de Zwart  1 , Annelies Riezebos-Brilman  2 , Huib A M Kerstjens  1 , Erik A M Verschuuren  1 , Jan-Willem C Alffenaar  3
Affiliations
Comment

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?

Auke E S de Zwart et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to De Zwart et al.
    Ackerson B. Ackerson B. Clin Infect Dis. 2020 May 6;70(10):2239-2240. doi: 10.1093/cid/ciz838. Clin Infect Dis. 2020. PMID: 31504294 No abstract available.

Comment on

References

    1. Ackerson B, Tseng HF, Sy LS, et al. . Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis 2018; 91101:197–203. - PMC - PubMed
    1. Behzadi MA, Leyva-Grado VH. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and middle east respiratory syndrome coronavirus infections. Front Microbiol 2019; 10:1327. - PMC - PubMed
    1. Chemaly RF, Aitken SL, Wolfe CR, Jain R, Boeckh MJ. Aerosolized ribavirin: the most expensive drug for pneumonia. Transpl Infect Dis 2016; 18:634–6. - PubMed
    1. Gross AE, Bryson ML. Oral ribavirin for the treatment of noninfluenza respiratory viral infections: a systematic review. Ann Pharmacother 2015; 49:1125–35. - PubMed
    1. Fuehner T, Dierich M, Duesberg C, et al. . Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections. Antivir Ther 2011; 16:733–40. - PubMed

MeSH terms